Cost-utility of aripiprazole once-monthly versus paliperidone palmitate once-monthly injectable for schizophrenia in China.
<h4>Objectives</h4>From the perspective of Chinese healthcare system, this study compared the cost-utility of aripiprazole once-monthly (AOM) and paliperidone palmitate once-monthly injectable (PP1M) in the treatment of adult patients with schizophrenia in China.<h4>Methods</h4>A 5-state Markov mode...
Gardado en:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Acceso en liña: | https://doi.org/10.1371/journal.pone.0317393 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|